Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016, Lancet Infect Dis, issue.18, pp.30475-30479, 2018. ,
The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management, Ther Adv Infect Dis, vol.5, issue.1, pp.29-43, 2017. ,
Status of vaccine research and development for enterotoxigenic Escherichia coli, Vaccine, vol.34, issue.26, pp.2880-2886, 2016. ,
Status of vaccine research and development for Shigella, Vaccine, vol.34, issue.26, pp.2887-94, 2016. ,
Human immune responses against Shigella and enterotoxigenic E. coli: current advances and the path forward, Vaccine, vol.35, pp.6803-6809, 2017. ,
Correlates of protection for enteric vaccines, Vaccine, vol.35, issue.26, pp.3355-63, 2017. ,
Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh, Infect Immun, vol.75, issue.8, pp.3961-3969, 2007. ,
Enumeration of gut-homing b7-positive, pathogen-specific antibodysecreting cells in whole blood from enterotoxigenic Escherichia coli-and vibrio cholerae-infected patients, determined using an enzyme-linked immunosorbent spot assay technique, Clin Vacc Immunol, vol.23, issue.1, pp.27-36, 2015. ,
Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults, PLoS Negl Trop Dis, vol.8, issue.4, 2014. ,
Recent progress toward an enterotoxigenic Escherichia coli vaccine, Expert Rev Vacc, vol.11, issue.4, pp.495-507, 2012. ,
Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine, Clin Diagn Lab Immunol, vol.8, issue.2, pp.424-432, 2001. ,
Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group, J Infect Dis, vol.179, issue.1, pp.107-121, 1999. ,
Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine, Infect Immun, vol.69, issue.5, pp.2853-2860, 2001. ,
Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico, Vaccine, vol.25, pp.4392-440, 2007. ,
Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea, J Infect Dis, vol.191, issue.4, pp.562-70, 2005. ,
Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebocontrolled Phase I study, Vaccine, vol.32, issue.52, pp.7077-84, 2014. ,
Induction of long term mucosal immunological memory in humans by an oral inactivated multivalent enterotoxigenic Escherichia coli vaccine, Vaccine, vol.34, issue.27, pp.3132-3172, 2016. ,
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses, Vaccine, issue.18, pp.31563-31572, 2018. ,
, Animal enterotoxigenic Escherichia coli. EcoSal Plus, vol.7, 2016.
The pig: a model for human infectious diseases, Trends Microbiol, vol.20, issue.1, pp.50-57, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-02652897
Targeting aminopeptidase N, a newly identified receptor for F4ac fimbriae, enhances the intestinal mucosal immune response, Mucosal Immunol, vol.5, issue.6, pp.635-680, 2012. ,
Recognition of blood group ABH type 1 determinants by the FedF adhesin of F18-fimbriated Escherichia coli, J Biol Chem, vol.284, issue.15, pp.9713-9739, 2009. ,
Enterotoxigenic Escherichia coli (K88) induce proinflammatory responses in porcine intestinal epithelial cells, Dev Comp Immunol, vol.34, issue.11, pp.1175-82, 2010. ,
F4+ ETEC infection and oral immunization with F4 fimbriae elicits an IL-17-dominated immune response, Vet Res, vol.21, issue.46, p.121, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01341430
Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae, Infect Immun, vol.67, issue.2, pp.520-526, 1999. ,
Different kinetic of antibody responses following infection of newly weaned pigs with an F4 enterotoxigenic Escherichia coli strain or an F18 verotoxigenic Escherichia coli strain, Vaccine, vol.20, pp.2995-3004, 2002. ,
Maternal immunity enhances systemic recall immune responses upon oral immunization of piglets with F4 fimbriae, Vet Res, vol.23, issue.46, p.72, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01336310
Orally fed seeds producing designer IgAs protect weaned piglets against enterotoxigenic Escherichia coli infection, Proc Natl Acad Sci, vol.110, issue.29, pp.11809-11823, 2013. ,
Differentiation of effector CD4 T cell populations (*), Annu Rev Immunol, vol.28, pp.445-89, 2010. ,
Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion, Immunity, vol.34, issue.1, pp.108-129, 2011. ,
Impact of CD4+ T cell responses on clinical outcome following oral administration of wild-type enterotoxigenic Escherichia coli in humans, PLoS Negl Trop Dis, vol.11, issue.1, p.5291, 2017. ,
Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells, Science, vol.314, issue.5802, pp.1157-60, 2006. ,
Activated T follicular helper-like cells are released into blood after oral vaccination and correlate with vaccine specific mucosal B-cell memory, Sci Rep, vol.8, issue.1, p.2729, 2018. ,
Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection, J Infect Dis, vol.125, issue.1, pp.12-18, 1972. ,
Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei, J Infect Dis, vol.164, pp.533-540, 1991. ,
Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile Am J Epidemiol, vol.134, issue.6, pp.614-641, 1991. ,
Recent trends in the epidemiology of shigellosis in Israel, Epidemiol Infect, vol.142, issue.12, pp.2583-94, 2014. ,
Epidemic spread of Shigella sonnei shigellosis and evidence for development of immunity among children attending day-care centers in a communal settlement (Kibbutz), J Clin Microbiol, vol.32, issue.4, pp.1092-1096, 1994. ,
Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis, J Clin Microbiol, vol.29, issue.2, pp.386-395, 1991. ,
Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population, J Infect Dis, vol.157, issue.5, pp.1068-71, 1988. ,
Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine, J Infect Dis, vol.155, issue.6, pp.1260-1265, 1987. ,
Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides, Clin Infect Dis, vol.15, issue.2, pp.346-61, 1992. ,
Polysaccharide-protein conjugates: a new generation of vaccines, J Infect Dis, vol.161, issue.5, pp.821-853, 1990. ,
Doubleblind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults, Lancet, vol.349, issue.9046, pp.155-164, 1997. ,
Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers, Infect Immun, vol.64, issue.10, pp.4074-4081, 1996. ,
Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children, Vaccine, vol.28, issue.10, pp.2231-2236, 2010. ,
A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection, J Immunol, vol.182, issue.4, pp.2241-2248, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00414256
A synthetic carbohydrate conjugate vaccine candidate against shigellosis: improved bioconjugation and impact of alum on immunogenicity, Bioconj Chem, vol.27, issue.4, pp.883-92, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01350027
Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1, Proc Natl Acad Sci, vol.96, pp.5194-5201, 1999. ,
B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection, J Exp Med, vol.211, issue.6, pp.1215-1244, 2014. ,
Pathogen manipulation of B cells: the best defence is a good offence, Nat Rev Microbiol, vol.13, issue.3, pp.173-84, 2015. ,
Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity, J Immunol, vol.184, issue.4, pp.2076-85, 2010. ,
Shigella deploy multiple countermeasures against host innate immune responses, Curr Opin Microbiol, vol.14, issue.1, pp.16-23, 2011. ,
Shigella are versatile mucosal pathogens that circumvent the host innate immune system, Curr Opin Immunol, vol.23, issue.4, pp.448-55, 2011. ,
An essential role for gamma interferon in innate resistance to Shigella flexneri infection, Infect Immun, vol.66, issue.4, pp.1342-1350, 1998. ,
Persistence of local cytokine production in shigellosis in acute and convalescent stages, Infect Immun, vol.63, issue.1, pp.289-96, 1995. ,
Local entrapment of interferon [gamma] in the recovery from Shigella dysenteriae type 1 infection, Gut, vol.38, pp.328-364, 1996. ,
Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers, Vaccine, vol.13, pp.88-97, 1995. ,
Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG, Infect Immun, vol.64, pp.4542-4550, 1996. ,
Production of IFN-c and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a shiga toxin-deleted Shigella dysenteriae type 1 strain, J Immunol, vol.164, issue.4, pp.2221-2253, 2000. ,
Phase 1 evaluation of a vriG deleted Shigella sonnei live, attenuated vaccine (strain WRSS1) in healthy adult volunteers, Infect Immun, vol.70, pp.2016-2037, 2002. ,
Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media, Hum Vaccin, vol.3, issue.6, pp.268-75, 2007. ,
T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans, J Transl Med, vol.16, issue.1, p.61, 2018. ,
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major, Nat Med, vol.13, issue.7, pp.843-50, 2007. ,
T-cell quality in memory and protection: implications for vaccine design, Nat Rev Immunol, vol.8, issue.4, pp.247-58, 2008. ,
Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a, Clin Immunol, vol.148, issue.1, pp.35-43, 2013. ,
Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates, Clin Immunol, vol.139, pp.185-92, 2011. ,
Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates, Vaccine, vol.27, issue.4, pp.565-572, 2009. ,
Correlates of protection induced by vaccination, Clin Vacc Immunol, vol.17, pp.1055-65, 2010. ,
Nomenclature for immune correlates of protection after vaccination, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.54, issue.11, pp.1615-1622, 2012. ,
A randomised, double blind, placebo-controlled challenge study to assess the protective efficacy of the single-dose oral typhoid vaccine, M01ZH09, PLoS Negl Trop Dis, vol.10, issue.8, p.4926, 2016. ,
Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans, J Transl Med, vol.1, issue.14, p.62, 2016. ,